The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Abstract
CONTEXT: Metabolic risk conferred by adiposity may be due to associated risk factor clustering. OBJECTIVE: The objective of this study was to assess risk for diabetes or cardiovascular disease (CVD) stratified by body mass index (BMI) and the presence or absence of metabolic syndrome (MetS) or insulin resistance (IR). DESIGN, SETTING, AND PARTICIPANTS: This was a community-based, longitudinal study of 2902 people (55% women, mean age 53 yr) without diabetes or CVD in 1989-1992 followed for up to 11 yr. We categorized subjects by normal weight (BMI < 25 kg/m(2)), overweight (25-29.9 kg/m(2)), or obese (>30 kg/m(2)) and by the National Cholesterol Education Program's Adult Treatment Panel MetS or the top quartile of homeostasis model IR. We used proportional hazard models to estimate risk relative to normal weight and no MetS or IR. MAIN OUTCOME MEASURE: Incident type 2 diabetes (treatment or fasting glucose > or = 7 mmol/liter, 141 events) or CVD (myocardial infarction, stroke, or claudication, 252 events) were measured. RESULTS: Among 1056 normal-weight subjects, 7% had MetS and a risk factor-adjusted relative risk for diabetes of 3.97 (95% confidence interval, 1.35-11.6) and for CVD of 3.01 (1.68-5.41). Among 638 obese subjects, 37% did not have MetS or significantly increased risk. Obese subjects with MetS had an adjusted relative risk for diabetes of 10.3 (5.44-19.5) and for CVD of 2.13 (1.43-3.18). Results were similar in analyses of BMI-IR categories. CONCLUSIONS: People with normal weight and MetS or IR or with obesity but no MetS or IR were not uncommon in our sample. Risk factor clustering or IR appear to confer much of the risk for diabetes or CVD commonly associated with elevated BMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Self-citationThe Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,280
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“5)] and defined IR as a homeostasis model assessment (HOMA)-IR level in the top quartile of the distribution among subjects without diabetes (17, 18).”
BackgroundObesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683 · cited 1×
“We estimated the population attributable fraction for diabetes or CVD associated with exposure categories (for instance, the normal weight with MetS category) as the proportion of cases in the exposure category [(RRexposure category 1)/ RRexposure category)] 100 (22).”
BackgroundAN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Cited by
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Blüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090
Kramer, C. K., Zinman, B., & Retnakaran, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00008 · Cited by 961
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
Abdullah, A., Peeters, A., de Courten, M., & Stoelwinder, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.012 · Cited by 824
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Metabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Characterizing the profile of obese patients who are metabolically healthy
Primeau, V, Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-E., Messier, V, Sladek, R., & Rabasa-Lhoret, R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 637
Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome
Myers, J., Kokkinos, P., & Nyelin, E. (2019) · Nutrients · doi:10.3390/nu11071652 · Cited by 630
Ärnlöv, J., Ingelsson, E., Sundström, J., & Lind, L. (2010) · Circulation · doi:10.1161/circulationaha.109.887521 · Cited by 611
The Concept of Normal Weight Obesity
Oliveros, E., Somers, V. K., Sochor, O., Goel, K., & Lopez-Jimenez, F. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.003 · Cited by 601
Metabolic Syndrome and Incident Diabetes
Ford, E. S., Li, C., & Sattar, N. (2008) · Diabetes Care · doi:10.2337/dc08-0423 · Cited by 577
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
Hamer, M., & Stamatakis, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3475 · Cited by 564
Mozumdar, A., & Liguori, G. (2011) · Diabetes Care · doi:10.2337/dc10-0879 · Cited by 551
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype
Appleton, S. L., Seaborn, C. J., Visvanathan, R., Hill, C. L., Gill, T. K., Taylor, A. W., Adams, R. J., & on behalf of the North West Adelaide Health Study Team (2013) · Diabetes Care · doi:10.2337/dc12-1971 · Cited by 478
Ortega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., & Blair, S. N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs174 · Cited by 468
Bell, J. A., Kivimaki, M., & Hamer, M. (2014) · Obesity Reviews · doi:10.1111/obr.12157 · Cited by 455
Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis.
Eckel, N., Meidtner, K., Kalle-Uhlmann, T., Stefan, N., & Schulze, M. B. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315623884 · Cited by 405
Thiazolidinediones: the forgotten diabetes medications
Lebovitz, H. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1270-y · Cited by 388
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Nabi, H., Brunner, E. J., Kivimaki, M., & Singh-Manoux, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu123 · Cited by 366
Metabolically healthy obesity: Definitions, determinants and clinical implications
Phillips, C. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9252-x · Cited by 355
Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals
Calori, G., Lattuada, G., Piemonti, L., Garancini, M. P., Ragogna, F., Villa, M., Mannino, S., Crosignani, P., Bosi, E., Luzi, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-0665 · Cited by 346
Metabolically Healthy Obesity and Risk of Mortality
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Batty, G. D., Kivimaki, M., & Singh-Manoux, A. (2013) · Diabetes Care · doi:10.2337/dc12-1654 · Cited by 317
Rey‐López, J. P., de Rezende, L. F., Pastor‐Valero, M., & Tess, B. H. (2014) · Obesity Reviews · doi:10.1111/obr.12198 · Cited by 310
Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
Stefan, N., Häring, H.-U., & Schulze, M. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30292-9 · Cited by 309
Leggio, M., Lombardi, M., Caldarone, E., Severi, P., D'Emidio, S., Armeni, M., Bravi, V., Bendini, M. G., & Mazza, A. (2017) · Hypertension Research · doi:10.1038/hr.2017.75 · Cited by 309
New obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Roberson, L. L., Aneni, E. C., Maziak, W., Agatston, A., Feldman, T., Rouseff, M., Tran, T., Blaha, M. J., Santos, R. D., Sposito, A., et al. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-14 · Cited by 305
Müller, M. J., Lagerpusch, M., Enderle, J., Schautz, B., Heller, M., & Bosy‐Westphal, A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01033.x · Cited by 292
Does Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults?
Phillips, C. M., & Perry, I. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2038 · Cited by 278
Threshold Values of High‐risk Echocardiographic Epicardial Fat Thickness
Iacobellis, G., Willens, H. J., Barbaro, G., & Sharma, A. M. (2008) · Obesity · doi:10.1038/oby.2008.6 · Cited by 276
Metabolically-Healthy Obesity and Coronary Artery Calcification
Chang, Y., Kim, B.-K., Yun, K. E., Cho, J., Zhang, Y., Rampal, S., Zhao, D., Jung, H.-S., Choi, Y., Ahn, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.042 · Cited by 272
van den Munckhof, I. C. L., Kurilshikov, A., ter Horst, R., Riksen, N. P., Joosten, L. A. B., Zhernakova, A., Fu, J., Keating, S. T., Netea, M. G., de Graaf, J., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12750 · Cited by 270
Metabolically healthy but obese individuals
Karelis, A. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61531-7 · Cited by 269
Meigs, J. B., Rutter, M. K., Sullivan, L. M., Fox, C. S., D'Agostino, R. B., & Wilson, P. W. F. (2007) · Diabetes Care · doi:10.2337/dc06-2484 · Cited by 268
Self-citationAung, K., Lorenzo, C., Hinojosa, M. A., & Haffner, S. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2832 · Cited by 266
Fan, J., Song, Y., Chen, Y., Hui, R., & Zhang, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.230 · Cited by 266
Metabolically Healthy Obesity: Criteria, Epidemiology, Controversies, and Consequences
Tsatsoulis, A., & Paschou, S. A. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00375-0 · Cited by 256
Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
Matthews, V. B., Elliot, R. H., Rudnicka, C., Hricova, J., Herat, L., & Schlaich, M. P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001434 · Cited by 222
Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes
Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-0817 · Cited by 220
Self-citationRisk Factors for Cardiovascular Disease in Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2016) · Diabetes · doi:10.2337/db15-1517 · Cited by 209
“Another risk factor established for CVD in type 2 diabetes (34) that did not emerge in our study was obesity or BMI.”
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Obesity · doi:10.1002/oby.20585 · Cited by 202
“This is consistent with the idea advanced by us (25) and others (17,18) that these diagnostic categories have high specificity but low sensitivity for identifying insulin resistance and cardiometabolic disease.”
InfluentialThe diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis
Philipps, L. H., Santhakumaran, S., Gale, C., Prior, E., Logan, K. M., Hyde, M. J., & Modi, N. (2011) · Diabetologia · doi:10.1007/s00125-011-2180-y · Cited by 182
Metabolically normal obese people are protected from adverse effects following weight gain
Fabbrini, E., Yoshino, J., Yoshino, M., Magkos, F., Tiemann Luecking, C., Samovski, D., Fraterrigo, G., Okunade, A. L., Patterson, B. W., & Klein, S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78425 · Cited by 172
(2007) · doi:10.1139/h06-102 · Cited by 160
Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity · doi:10.1038/oby.2008.308 · Cited by 158
Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women
Kabat, G. C., Kim, M. Y., Lee, J. S., Ho, G. Y., Going, S. B., Beebe-Dimmer, J., Manson, J. E., Chlebowski, R. T., & Rohan, T. E. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0495 · Cited by 136
Hamer, M., Batty, G. D., & Kivimaki, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.30 · Cited by 132
Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults
Camhi, S. M., Whitney Evans, E., Hayman, L. L., Lichtenstein, A. H., & Must, A. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.04.023 · Cited by 111
“, 2007) and lower incidence of cardiovascular disease and type II diabetes when compared to their metabolically abnormal obese (MAO) counterparts (Meigs et al., 2006).”
BackgroundRole of the gut in visceral fat inflammation and metabolic disorders
Lam, Y. Y., Mitchell, A. J., Holmes, A. J., Denyer, G. S., Gummesson, A., Caterson, I. D., Hunt, N. H., & Storlien, L. H. (2011) · Obesity · doi:10.1038/oby.2011.68 · Cited by 97
Kokkinos, A., Alexiadou, K., Liaskos, C., Argyrakopoulou, G., Balla, I., Tentolouris, N., Moyssakis, I., Katsilambros, N., Vafiadis, I., Alexandrou, A., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0743-8 · Cited by 90
Kendzor, D. E., Chen, M., Reininger, B. M., Businelle, M. S., Stewart, D. W., Fisher-Hoch, S. P., Rentfro, A. R., Wetter, D. W., & McCormick, J. B. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-176 · Cited by 55
“Numerous studies have shown that obesity and weight gain are linked with the onset of diabetes [4-6].”
BackgroundDepressive symptoms, anxiety and well-being among metabolic health obese subtypes
Phillips, C. M., & Perry, I. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.168 · Cited by 48
“Metabolic health status was defined using three existing MH definitions based on a range of cardiometabolic abnormalities including the metabolic syndrome criteria, insulin resistance and inflammation (Meigs et al., 2006; Wildman et al., 2008) (Table 1).”
Fu, J., Li, Y., Esangbedo, I. C., Li, G., Feng, D., Li, L., Xu, L., Han, L., Li, M., Li, C., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009169 · Cited by 37
Donini, L., Merola, G., Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Migliaccio, S., & Lenzi, A. (2016) · Nutrients · doi:10.3390/nu8120759 · Cited by 32
van den Broek-Altenburg, E., Atherly, A., & Holladay, E. (2022) · BMC Public Health · doi:10.1186/s12889-022-13176-y · Cited by 27
“Obesity has been linked to a multitude of health conditions, including coronary heart disease [7], chronic renal failure [8], many cancers, sleep apnea, gallbladder disease [9], Type 2 Diabetes [10] and other conditions.”
BackgroundEarly Insulin Use in Type 2 Diabetes
Chiasson, J.-L. (2009) · Diabetes Care · doi:10.2337/dc09-s321 · Cited by 24
Higher Adiponectin Levels Predict Greater Weight Gain in Healthy Women in the Nurses' Health Study
Hivert, M., Sun, Q., Shrader, P., Mantzoros, C. S., Meigs, J. B., & Hu, F. B. (2011) · Obesity · doi:10.1038/oby.2010.189 · Cited by 24
Self-citationIs it time to think about the sodium glucose co‐transporter 2 sympathetically?
Elliott, R. H., Matthews, V. B., Rudnicka, C., & Schlaich, M. P. (2016) · Nephrology · doi:10.1111/nep.12620 · Cited by 23
Straznicky, N. E., Lambert, E. A., Grima, M. T., Eikelis, N., Richards, K., Nestel, P. J., Dawood, T., Masuo, K., Sari, C. I., Dixon, J. B., et al. (2014) · Obesity · doi:10.1002/oby.20614 · Cited by 21
Xu, R., Gao, X., Wan, Y., & Fan, Z. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14025 · Cited by 18
Metadata
- Authors
- Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-08
- Volume
- 91
- Issue
- 8
- Pages
- 2906-2912
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2119609179
- Cited by
- 1,062
- References
- 56
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.